Showing results 1 to 6 of 6
HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer Jung, Kyung Hee; Yan, Hong Hua; Fang, Zhenghuan; Son, Mi Kwon; Lee, Hyunseung; Hong, Sungwoo; Hong, Soon-Sun, INTERNATIONAL JOURNAL OF ONCOLOGY, v.45, no.1, pp.311 - 321, 2014-07 |
HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer Park, Jung Hee; Jung, Kyung Hee; Kim, Soo Jung; Yoon, Young-Chan; Yan, Hong Hua; Fang, Zhenghuan; Lee, Ji Eun; et al, CANCER LETTERS, v.444, pp.94 - 104, 2019-01 |
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer Rumman, Marufa; Jung, Kyung Hee; Fang, Zhenghuan; Yan, Hong Hua; Son, Mi Kwon; Kim, Soo Jung; Kim, Juyoung; et al, ONCOTARGET, v.7, no.47, pp.78029 - 78047, 2016-11 |
HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia Yun, Sun-Mi; Jung, Kyung Hee; Kim, Soo Jung; Fang, Zhenghuan; Son, Mi Kwon; Yan, Hong Hua; Lee, Hyunseung; et al, CANCER LETTERS, v.348, no.1-2, pp.50 - 60, 2014-06 |
Optimization and biological evaluation of aminopyrimidine-based I kappa B kinase beta inhibitors with potent anti-inflammatory effects Shin, Yongje; Lim, Sang Min; Yan, Hong Hua; Jung, Sungwoo; Fang, Zhenghuan; Jung, Kyung Hee; Hong, Soon-Sun; et al, EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.123, pp.544 - 556, 2016-11 |
Synthesis of gemcitabine-threonine amide prodrug effective on pancreatic cancer cells with improved pharmacokinetic properties Hong, Sungwoo; Fang, Zhenghuan; Jung, Hoi Yun; Yoon, Jin-Ha; Hong, Soon-Sun; Maeng, Han-Joo, MOLECULES, v.23, no.10, 2018-10 |
Discover